Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,975 | -3,834 | -2,951 | -1,180 | -5,134 |
| Depreciation Amortization | 2,080 | 1,850 | 1,199 | 65 | 224 |
| Accounts receivable | -116 | -158 | 492 | 427 | -2,338 |
| Accounts payable and accrued liabilities | N/A | N/A | -850 | -486 | N/A |
| Other Working Capital | -1,446 | -1,731 | -1,236 | -599 | -7,626 |
| Other Operating Activity | 127 | 158 | 357 | 59 | 2,350 |
| Operating Cash Flow | $-5,331 | $-3,715 | $-2,987 | $-1,714 | $-12,525 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -175 | -165 | -168 | -8 | -1,657 |
| Purchase Sale Intangibles | -662 | -621 | -595 | -205 | -322 |
| Other Investing Activity | -662 | -621 | -500 | -169 | -322 |
| Investing Cash Flow | $-836 | $-786 | $-668 | $-176 | $-1,979 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,748 | 4,024 | 4,024 | 355 | 12,081 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -3,140 |
| Other Financing Activity | 0 | 0 | -76 | -17 | 0 |
| Financing Cash Flow | $4,748 | $4,024 | $3,948 | $338 | $8,942 |
| Exchange Rate Effect | 856 | 97 | 326 | -10 | -1,043 |
| Beginning Cash Position | 9,687 | 9,687 | 9,687 | 9,687 | 16,292 |
| End Cash Position | 9,123 | 9,306 | 10,305 | 8,125 | 9,687 |
| Net Cash Flow | $-563 | $-380 | $619 | $-1,562 | $-6,606 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,331 | -3,715 | -2,987 | -1,714 | -12,525 |
| Capital Expenditure | -175 | -176 | -168 | -8 | -1,657 |
| Free Cash Flow | -5,506 | -3,891 | -3,155 | -1,721 | -14,182 |